Concepedia

Author

Christoph Nerl

München Klinik Schwabing

Also Known As

C Nerl, CHRISTOPH NERL, Christoph Nerl, Dieter K. Hossfeld, Stefan W. Krause

66

Publications

3.3K

Citations

22

H-Index

39

Concepts

All Affiliations

München Klinik SchwabingLudwig-Maximilians-Universität MünchenUniversity Hospital of BernHeidelberg UniversityUniversity Hospital of Basel
CN

About

Christoph Nerl is an author at München Klinik Schwabing specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

403

2

Allergy

2

2

48

3

Health Sciences

1

1

51

4

Allergy Medicine

1

1

27

5

Blood Transplantation

1

1

51

Christoph Nerl

×

32

Publications

3.1K

Citations

21

H-Index

YearCitations

Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study

Peter Reimer, Thomas Rüdiger, Eva Geissinger,

Journal of Clinical Oncology

2008

422

Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.

Wolfgang Römer, Axel-R. Hanauske, Sibylle Ziegler,

PubMed

1998

338

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz,

Journal of Clinical Oncology

2011

321

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

Rüdiger Hehlmann, Martin C. Müller, Michael Lauseker,

Journal of Clinical Oncology

2013

296

Intracellular and Surface Expression of the HIV-1 Coreceptor CXCR4/Fusin on Various Leukocyte Subsets: Rapid Internalization and Recycling Upon Activation

Reinhold Förster, Elisabeth Kremmer, Andreas Schubel,

The Journal of Immunology

1998

257

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

Michael Hallek, Irmgard Langenmayer, Christoph Nerl,

PubMed

1999

236

Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group

Peter Borchmann, Heinz Haverkamp, Volker Diehl,

Journal of Clinical Oncology

2011

186

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia

Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann,

Blood

2007

168

Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group

Michael Hallek, Barbara Schmitt, Martin Wilhelm,

British Journal of Haematology

2001

122

Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells

Robert Dengler, Ursula Muunstermann, S. Al-Batran,

British Journal of Haematology

1995

102

Page 1